treatments
CAR-T therapy for myeloma in China
T cells are a type of white blood cell that develop from stem cells in bone marrow. As part of the immune system, T cells help destroy abnormal cells and pathogens. In multiple myeloma, the T cells don’t recognize cancer cells as harmful. The goal of CAR T-cell therapy is to correct that error. In autologous CAR T-cell therapy, the treatment uses your own T cells. It starts with an intravenous (IV) blood draw.
CAR-T therapy for leukaemia in China
T cells are a type of white blood cell that develop from stem cells in bone marrow. As part of the immune system, T cells help destroy abnormal cells and pathogens. In multiple myeloma, the T cells don’t recognize cancer cells as harmful. The goal of CAR T-cell therapy is to correct that error. In autologous CAR T-cell therapy, the treatment uses your own T cells. It starts with an intravenous (IV) blood draw.
CAR-T therapy for lymphoma in China
T cells are a type of white blood cell that develop from stem cells in bone marrow. As part of the immune system, T cells help destroy abnormal cells and pathogens. In multiple myeloma, the T cells don’t recognize cancer cells as harmful. The goal of CAR T-cell therapy is to correct that error. In autologous CAR T-cell therapy, the treatment uses your own T cells. It starts with an intravenous (IV) blood draw.